As genetic and biomarker tests become more common, so do new therapies that target specific tumor types and may lead to ...

Due to federal research cuts, Navy veteran Kyle Lewis says he won't be able to receive the cancer treatment that saved his ...

The Food and Drug Administration (FDA) has approved Imfinzi (durvalumab) for adults with limited-stage small cell lung cancer ...

Among patients with resectable non-small cell lung cancer, Opdivo plus Yervoy has displayed potential long-term clinical ...

Joe Leach, MD, discusses some of the latest developments in incorporating immunotherapy into small cell lung cancer treatment regimens.

Cancer is a complex condition marked by the uncontrolled growth of cells in the body. When this process begins in the lungs, ...

Discover the four vital indicators that your cancer treatment is effective, from tumor shrinkage to symptom relief, helping ...

Colonoscopies, mammograms, Pap smears and prostate exams are designed to detect early signs of cancer. Local health care ...

The researchers found that factors favoring chemoimmunotherapy included higher socioeconomic status, being uninsured, a more ...

The agreement was signed in a letter of intent March 3 to set the groundwork for whether government health programs in ...

AstraZeneca is preparing to talk to the FDA about a potential new use of its immunotherapy Imfinzi after a pivotal study in ...

EMA committee recommends approval of AstraZeneca’s Imfinzi in combo with chemotherapy to treat resectable non-small cell lung cancer ...